These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 7485251

  • 1. Schizophrenia: gender, family risk, and plasma homovanillic acid.
    Dávila R, Zumárraga M, González-Torres MA, Andía I, Zamalloa MI, Basterreche E, Guimón J, Friedhoff AJ.
    Am J Med Genet; 1995 Apr 24; 60(2):154-6. PubMed ID: 7485251
    [Abstract] [Full Text] [Related]

  • 2. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
    Davila R, Gonzalez MA, Zumarraga M, Andia I, Guimon J, Silva RR, Friedhoff AJ.
    Biol Psychiatry; 1995 Aug 15; 38(4):267-9. PubMed ID: 8547450
    [No Abstract] [Full Text] [Related]

  • 3. Plasma catecholamine metabolites and early response to haloperidol.
    Bowers MB, Swigar ME, Jatlow PI, Goicoechea N.
    J Clin Psychiatry; 1984 Jun 15; 45(6):248-51. PubMed ID: 6725216
    [Abstract] [Full Text] [Related]

  • 4. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decrease.
    Newcomer JW, Riney SJ, Vinogradov S, Csernansky JG.
    Psychopharmacol Bull; 1992 Jun 15; 28(1):101-7. PubMed ID: 1609034
    [Abstract] [Full Text] [Related]

  • 5. Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance.
    Akiyama K, Tsuchida K, Kanzaki A, Ujike H, Hamamura T, Kondo K, Mutoh S, Miyanagi K, Kuroda S, Otsuki S.
    Biol Psychiatry; 1995 Nov 15; 38(10):639-48. PubMed ID: 8555375
    [Abstract] [Full Text] [Related]

  • 6. Plasma homovanillic acid levels in schizophrenic patients: correlation with negative symptoms.
    Dávila R, Zumárraga M, Basterreche N, Arrúe A, Anguiano JB.
    Psychiatry Res; 2007 May 30; 151(1-2):163-8. PubMed ID: 17434602
    [Abstract] [Full Text] [Related]

  • 7. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I, Castro-Fornieles J, Deulofeu R, de la Serna E, Goti J, Salvà J, Bernardo M.
    Psychiatry Res; 2009 Jul 30; 168(2):110-8. PubMed ID: 19501918
    [Abstract] [Full Text] [Related]

  • 8. Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.
    Suzuki E, Kanba S, Koshikawa H, Nibuya M, Yagi G, Asai M.
    J Psychiatry Neurosci; 1996 May 30; 21(3):167-71. PubMed ID: 8935328
    [Abstract] [Full Text] [Related]

  • 9. Effects of debrisoquin on plasma homovanillic acid concentration in schizophrenic patients.
    Davidson M, Losonczy MF, Mohs RC, Powchick P, Freed LB, Kaminsky R, Davis KL.
    Psychopharmacol Bull; 1987 May 30; 23(3):407-10. PubMed ID: 3432512
    [No Abstract] [Full Text] [Related]

  • 10. Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients.
    Davidson M, Losonczy MF, Mohs RC, Lesser JC, Powchik P, Freed LB, Davis BM, Mykytyn VV, Davis KL.
    Neuropsychopharmacology; 1987 Dec 30; 1(1):17-23. PubMed ID: 3509064
    [Abstract] [Full Text] [Related]

  • 11. Apomorphine has no effect on plasma homovanillic acid in schizophrenic patients.
    Davidson M, Kendler KS, Davis BM, Horvath TB, Mohs RC, Davis KL.
    Psychiatry Res; 1985 Oct 30; 16(2):95-9. PubMed ID: 3865258
    [Abstract] [Full Text] [Related]

  • 12. Plasma homovanillic acid as a predictor of response to neuroleptics.
    Davila R, Manero E, Zumarraga M, Andia I, Schweitzer JW, Friedhoff AJ.
    Arch Gen Psychiatry; 1988 Jun 30; 45(6):564-7. PubMed ID: 3377643
    [Abstract] [Full Text] [Related]

  • 13. Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement.
    Nibuya M, Kanba S, Sekiya U, Suzuki E, Matsuo Y, Kinoshita N, Shintani F, Yagi G, Asai M.
    Biol Psychiatry; 1995 Jul 01; 38(1):50-6. PubMed ID: 7548472
    [Abstract] [Full Text] [Related]

  • 14. Neuroleptic treatment, symptoms of schizophrenia, and plasma homovanillic acid concentrations revisited.
    Volavka J, Douyon R, Convit A, Czobor P, Cooper TB.
    Arch Gen Psychiatry; 1992 Dec 01; 49(12):999-1000. PubMed ID: 1449388
    [No Abstract] [Full Text] [Related]

  • 15. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.
    Davidson M, Kahn RS, Knott P, Kaminsky R, Cooper M, DuMont K, Apter S, Davis KL.
    Arch Gen Psychiatry; 1991 Oct 01; 48(10):910-3. PubMed ID: 1929760
    [Abstract] [Full Text] [Related]

  • 16. Plasma homovanillic acid, serum anti-D1 and anti-D2 receptor activity, and psychopathology in chronic schizophrenia.
    Koshikawa H, Suzuki E, Kanba S, Nibuya M, Ishizuki T, Kohno H, Kinoshita N, Shintani F, Yagi G, Nakaki T.
    Yakubutsu Seishin Kodo; 1991 Feb 01; 11(1):79-81. PubMed ID: 1679276
    [No Abstract] [Full Text] [Related]

  • 17. Relationship of symptomatology, gender, and antipsychotic drug treatment with plasma homovanillic acid in schizophrenia.
    Zhang ZJ, Reynolds GP, Ramchand C, Peet M, Shah S.
    Acta Pharmacol Sin; 2001 Jan 01; 22(1):76-80. PubMed ID: 11730567
    [Abstract] [Full Text] [Related]

  • 18. Sex differences in plasma homovanillic acid in acute psychosis.
    Bowers MB, Swigar ME, Jatlow PI.
    N Engl J Med; 1983 Apr 07; 308(14):845-6. PubMed ID: 6835278
    [No Abstract] [Full Text] [Related]

  • 19. Plasma homovanillic acid as a predictor of response to fluphenazine treatment.
    Van Putten T, Marder SR, Aravagiri M, Chabert N, Mintz J.
    Psychopharmacol Bull; 1989 Apr 07; 25(1):89-91. PubMed ID: 2772121
    [No Abstract] [Full Text] [Related]

  • 20. First-episode neuroleptic-free schizophrenics: concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment.
    Nagaoka S, Iwamoto N, Arai H.
    Biol Psychiatry; 1997 Apr 15; 41(8):857-64. PubMed ID: 9099412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.